This is a grant in response to NCI RFA 89-CA-06 for the creation of the Kings County Minority Based Community Clinical Oncology Program (KCMB-CCOP) constituted of a consortium of the oncology services of four hospital components: Kings County Hospital Center (KCHC) and Interfaith Medical Center (IFMC), the dominant components that register 90% minority patients among their annual number of new cancer patients and Brooklyn Veterans Administration Hospital (BVAH) and Long Island College Hospital (LICH), two component that have strong clinical laboratories and a reputed surgical oncology service. The major aims of this proposal is to bring the advantages of state of the art treatment and cancer control research to 700,000 minority inhabitants in the northern part of the County of Kings, Borough of Brooklyn of which 1/3 live in poverty ad look for medical care at the time their neoplasms are in advanced stages. This proposal will also aim at involving in research a new segment of physicians (primary care physicians and surgeons) and at facilitating a more rapid dissemination at the level of minority populations newly developed techniques in cancer treatment and prevention. In order to achieve these goals patients will be entered in clinical trials from two research bases: the Southwestern Oncology Group (SWOG) and Memorial Sloan-Kettering Cancer Center (MSKCC). A minimum of 60 new patients a year in treatment protocols and 30 new patients a year in cancer control protocols of which 65-70% will be minority patients will be selected from an annual base of 1950 registered cancer patients. To secure proper eligibility and followup of these patients main emphasis will be placed in developing well organized and efficient data manager group with a fulltime data manager at each of the dominant components (KCHC and IFMC) a parttime data manager at each of the nondominant components and a coordinator working directly with the principal investigator. Recruited primarily from a pool of registered nurses these data managers will also directly participate in some of the cancer screening protocols. A cancer prevention education program will be implemented through flyers and video camera systems in the emergency rooms and clinics of the dominant components; the attendance of scientific meetings of the research bases by KCMB-CCOP participating physicians will be supported. It is felt that this program will succeed to significantly improve the care of cancer patients and expand cancer control activities among the minority population of the County of Kings (Brooklyn) and will attract in clinical research, a new group of physicians.

Agency
National Institute of Health (NIH)
Institute
National Cancer Institute (NCI)
Type
Cooperative Clinical Research--Cooperative Agreements (U10)
Project #
3U10CA052772-03S1
Application #
3558973
Study Section
Special Emphasis Panel (SRC (42))
Project Start
1990-09-01
Project End
1994-05-31
Budget Start
1993-06-01
Budget End
1994-05-31
Support Year
3
Fiscal Year
1993
Total Cost
Indirect Cost
Name
Suny Downstate Medical Center
Department
Type
Schools of Medicine
DUNS #
068552207
City
Brooklyn
State
NY
Country
United States
Zip Code
11203
Gordon, M A; Gundacker, H M; Benedetti, J et al. (2013) Assessment of HER2 gene amplification in adenocarcinomas of the stomach or gastroesophageal junction in the INT-0116/SWOG9008 clinical trial. Ann Oncol 24:1754-61
Tangen, Catherine M; Hussain, Maha H A; Higano, Celestia S et al. (2012) Improved overall survival trends of men with newly diagnosed M1 prostate cancer: a SWOG phase III trial experience (S8494, S8894 and S9346). J Urol 188:1164-9
Chu, David Z J; Hussey, Michael A; Alberts, David S et al. (2011) Colorectal Chemoprevention Pilot Study (SWOG-9041), randomized and placebo controlled: the importance of multiple luminal lesions. Clin Colorectal Cancer 10:310-6
Albain, Kathy S; Barlow, William E; Shak, Steven et al. (2010) Prognostic and predictive value of the 21-gene recurrence score assay in postmenopausal women with node-positive, oestrogen-receptor-positive breast cancer on chemotherapy: a retrospective analysis of a randomised trial. Lancet Oncol 11:55-65
Albain, Kathy S; Barlow, William E; Ravdin, Peter M et al. (2009) Adjuvant chemotherapy and timing of tamoxifen in postmenopausal patients with endocrine-responsive, node-positive breast cancer: a phase 3, open-label, randomised controlled trial. Lancet 374:2055-63
Swinnen, Lode J; Rankin, Cathryn; Carraway, Hetty et al. (2008) A phase II study of cisplatin preceded by a 12-h continuous infusion of concurrent hydroxyurea and cytosine arabinoside (Ara-C) for adult patients with malignant gliomas (Southwest Oncology Group S9149). J Neurooncol 86:353-8
Rusch, Valerie W; Giroux, Dorothy J; Kraut, Michael J et al. (2007) Induction chemoradiation and surgical resection for superior sulcus non-small-cell lung carcinomas: long-term results of Southwest Oncology Group Trial 9416 (Intergroup Trial 0160). J Clin Oncol 25:313-8
Smalley, Stephen R; Benedetti, Jacqueline K; Williamson, Stephen K et al. (2006) Phase III trial of fluorouracil-based chemotherapy regimens plus radiotherapy in postoperative adjuvant rectal cancer: GI INT 0144. J Clin Oncol 24:3542-7
Beer, Tomasz M; Tangen, Catherine M; Bland, Lisa B et al. (2006) The prognostic value of hemoglobin change after initiating androgen-deprivation therapy for newly diagnosed metastatic prostate cancer: A multivariate analysis of Southwest Oncology Group Study 8894. Cancer 107:489-96
Leichman, Cynthia G; Benedetti, Jacqueline K; Zalupski, Mark M et al. (2005) Assessment of infusional 5-fluorouracil schedule and dose intensity: a Southwest Oncology Group and Eastern Cooperative Oncology Group study. Clin Colorectal Cancer 5:119-23

Showing the most recent 10 out of 14 publications